Results 201 to 210 of about 33,041 (261)

Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders. [PDF]

Cells
Yasui H, Idogawa M, Ishida T, Imai K.
europepmc   +1 more source

Management of Primary Refractory Diffuse Large B‐Cell Lymphoma in Patients Unsuitable for CAR T‐Cell Therapy

European Journal of Haematology, Volume 116, Issue 6, Page 771-784, June 2026.
ABSTRACT Primary refractory Diffuse Large B‐Cell Lymphoma is associated with poor outcomes and limited responsiveness to conventional salvage therapies. Although CAR T‐cell therapy represents the standard of care in this setting, a substantial proportion of patients cannot receive it despite meeting disease‐related criteria. In this review, “unsuitable”
Santino Caserta, Enrica Antonia Martino, Mamdouh Skafi, Maria Eugenia Alvaro, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Ernesto Vigna, Fortunato Morabito, Massimo Gentile   +12 more
wiley   +1 more source

AI-guided CAR designs and targeted pathway modulation to enhance multi-antigen CAR T cell durability and overcome antigen escape. [PDF]

Nat Commun
Ansari MS, Chauhan V, Singh A, Akhtar A, Chaudhary N, Tyagi R, Divya, Husain K, Sharma S, Alam R, Shakir M, Pracha M, Anjum S, Nadeem M, Taneja P, Faizan MI, Azmi I, Iyer AR, Gupta P, Nafiz M, Ali S, Uddin IM, Javid M, Bhat ZA, Palani HK, Srivastava AK, Mabalirajan U, Mathews V, Husain M, Ramalingam S, Kharya G, Ahmad T.   +31 more
europepmc   +1 more source

The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein-Barr Virus-Linked Disease? [PDF]

Open Forum Infect Dis
Onisiforou A.
europepmc   +1 more source

Erythrocyte patch for enhanced B cell depletion therapy. [PDF]

Sci Adv
Liu J, Wang F, Li L.
europepmc   +1 more source

Extracellular payload release from non-internalizing antibody-drug conjugates: mechanisms and linker technologies. [PDF]

Drug Deliv
Feng C, Lou R, Chen S, Lin F, Ge J, Zhang Y, Lin C, Huang C.   +7 more
europepmc   +1 more source

CD72 downregulation on DN2 B cells is associated with disease activity and resistance to rituximab in systemic lupus erythematosus. [PDF]

Rheumatology (Oxford)
Wangriatisak K, Huang W, Sechi G, Oke V, Chemin K, Grönwall C, Gunnarsson I, Malmström V, Faustini F.   +8 more
europepmc   +1 more source

EBV Early Lytic Antigens, EBNA2 and PDL-1, in Progressive Multiple Sclerosis Brain: A Coordinated Contribution to Viral Immune Evasion. [PDF]

Int J Mol Sci
Benincasa L, Rosicarelli B, Meloni C, Serafini B.   +3 more
europepmc   +1 more source

Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs. [PDF]

Vet Pathol
Giusti AM, Sam J, Colombetti S, Veiga IB, Monné Rodríguez JM.   +4 more
europepmc   +1 more source

CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomas. [PDF]

Blood Neoplasia
Gholy SM, Ranadóttir T, Davidsson OB, Kristjánsson RP, Kadlec TF, Vainer N, Katsimigas A, Werling M, Kyvsgaard E, Husby S, da Cunha-Bang C, Rostgaard K, Hutchings M, Brown P, Hjalgrim H, Niemann CU, Brieghel C, Dietz JB.   +17 more
europepmc   +1 more source